TPD & Induced Proximity Summit Leaderboard
  • Saturday, July 11, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

Oligonucleotides Analytical Development & CMC Summit Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 444

Author

Pharma Journalist 8932 posts 0 comments

Apellis and Sobi Enter Collaboration for Global Co-development and Ex-US Commercialization of…

Oct 28, 2020
Apellis Pharmaceuticals, Inc. and Swedish Orphan Biovitrum AB (publ) announced a strategic collaboration to accelerate the advancement of systemic pegcetacoplan, a targeted C3 therapy,…
Read More...

Kala Pharmaceuticals Announces FDA Approval of EYSUVIS for the Short-Term Treatment of the Signs and…

Oct 27, 2020
Kala Pharmaceuticals, Inc. a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye announced that the…
Read More...

Histogen and Amerimmune Enter into a Collaborative Development and Commercialization Agreement for…

Oct 27, 2020
Histogen Inc. a clinical-stage therapeutics company focused on developing potential first-in-class therapeutics that ignite the body’s natural process to repair and maintain healthy…
Read More...

SFJ Pharmaceuticals partner, Apellis, enters Strategic Collaboration with Sobi to Develop and…

Oct 27, 2020
SFJ Pharmaceuticals is pleased to note that its partner Apellis Pharmaceuticals Inc. and Swedish Orphan Biovitrum AB announced a strategic collaboration to accelerate the advancement of…
Read More...

HiFiBiO Therapeutics Completes First Cohort of a Phase I Study of its SARS-CoV-2 Neutralizing…

Oct 27, 2020
HiFiBiO Therapeutics, a multinational biotherapeutics company with unique expertise in immune modulation and single-cell science, today announced the successful completion of the first…
Read More...

Knight Signs New Exclusive AmBisome Agreement with Gilead in Brazil

Oct 27, 2020
Knight Therapeutics Inc. a leading pan-American (ex-US) specialty pharmaceutical company, announced the signing of a new exclusive distribution agreement with Gilead Sciences, Inc. for…
Read More...

Bayer acquires Asklepios BioPharmaceutical to broaden innovation base in cell and gene therapy

Oct 27, 2020
Bayer AG announced the acquisition of Asklepios BioPharmaceutical, Inc. (AskBio), a US-headquartered biopharmaceutical company specialized in the research, development and manufacturing…
Read More...

ANA Therapeutics Begins Phase 2/3 Clinical Trial of Proprietary Oral Niclosamide Formulation to…

Oct 27, 2020
ANA Therapeutics announced that it has begun a multicenter, Phase 2/3 clinical trial to evaluate the safety and efficacy of its proprietary, oral niclosamide (ANA001) formulation for…
Read More...

Moderna Announces Supply Agreement with the Ministry of Public Health to Supply Qatar with mRNA…

Oct 27, 2020
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced a supply…
Read More...

FDA authorises restart of the COVID-19 AZD1222 vaccine US Phase III trial

Oct 26, 2020
Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed across the world with regulators in the US, UK, Brazil, South Africa and Japan confirming that it…
Read More...
Prev Next
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
2nd Operationalize: Expanded Access Programs Summit West
Neuropsychiatric Drug Development Summit
International Neoantigen Summit
Lab Ops & Facility Management for Biopharma West Summit
10th IPF Summit
Medical Device Software Development Summit
Liquid Biopsy for Precision Oncology Summit East Coast
ADC Linker & Conjugation Summit
Cell & Gene Therapy Summit South Korea
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
In Vivo Cell Engineering & Gene Editing Summit
Obesity & Weight Loss Drug Development Summit
T-Cell Engager Therapeutics Summit
mRNA-Based Therapeutics Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • Roche Receives CE Mark for Elecsys Latent TB Test
  • Teva Secures Global Rights to Polpharma’s Ocrevus Biosimilar
  • Samsung Bioepis Partners With Proteina on AI Antibody Drug Discovery
  • Evogene, Tel Aviv University Launch AI Drug Discovery Initiative
  • Wainua Misses Primary Endpoint in ATTR-CM Phase III Trial

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Advancing Respiratory Medicine Following ATS – What Now?

World ADC San Diego Unveils Preliminary Agenda for 17th…

Regeneron Goes All In on Radiopharma with $2.1B Telix Deal…

IQ MPS Leaders to Share Industry Progress on Advancing In…

4th ADC Linker & Conjugation Summit Announces 2026…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.